Fentanyl Identification On the Street and In the Lab

Baxter considers sale of kidney care unit to PE firm: WSJ

Dive Brief: Baxter is considering the sale of its kidney care business to private equity firm Carlyle Group for more than $4 billion, The Wall

July 8, 2024

FDA expands total product life cycle program to cover neurological devices

Dive Brief: The Food and Drug Administration is expanding a program for accelerating device development to cover neurological and physical medicine technologies. Initially, the voluntary

October 3, 2023

What to Know About Nitazenes, a Class of Potent Synthetic Opioids

A class of synthetic opioids known as the nitazenes that are as potent as fentanyl — or stronger — have been increasingly involved in deaths

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.